Please assess the completion status of the following clinical trial:

Trial Title: Closure of Protective Ileostomy 2 vs. 12 Weeks After TME

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* anastomosis ≤ 5cm from anal verge~* age \>18 years~* informed consent~* uneventful course after first operation~Exclusion Criteria:~* pregnancy~* allergy to contrast agent~* severe non-surgical complications~* evident abdominal - pelvic complications

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 2 weeks (Type: EXPERIMENTAL): Ileostomy closure after 2 weeks
- 12 weeks (Type: EXPERIMENTAL): Ileostomy closure after 12 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).